-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $22 Price Target

Benzinga·11/09/2026 16:53:05
Diffusion vocale
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Vir Biotechnology (NASDAQ:VIR) with a Buy and maintains $22 price target.